Verition Fund Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,932,153
| Closed | -$8.12M | – | 2433 |
|
|
2023
Q1 | $8.12M | Buy |
1,932,153
+476,564
| +33% | +$2M | 0.11% | 213 |
|
|
2022
Q4 | $8.75M | Buy |
1,455,589
+214,278
| +17% | +$1.29M | 0.14% | 158 |
|
|
2022
Q3 | $7.22M | Sell |
1,241,311
-43,014
| -3% | -$250K | 0.08% | 247 |
|
|
2022
Q2 | $7.67M | Buy |
1,284,325
+289,045
| +29% | +$1.73M | 0.15% | 150 |
|
|
2022
Q1 | $4.65M | Sell |
995,280
-150,000
| -13% | -$701K | 0.06% | 304 |
|
|
2021
Q4 | $2.84M | Buy |
1,145,280
+9,231
| +0.8% | +$22.9K | 0.02% | 459 |
|
|
2021
Q3 | $3.35M | Buy |
1,136,049
+157,370
| +16% | +$464K | 0.03% | 283 |
|
|
2021
Q2 | $2.45M | Sell |
978,679
-133,001
| -12% | -$333K | 0.02% | 370 |
|
|
2021
Q1 | $3.24M | Buy |
1,111,680
+122,078
| +12% | +$355K | 0.04% | 225 |
|
|
2020
Q4 | $3.19M | Buy |
989,602
+218,871
| +28% | +$705K | 0.03% | 210 |
|
|
2020
Q3 | $1.66M | Buy |
+770,731
| New | +$1.66M | 0.03% | 228 |
|
|
2018
Q2 | – | Sell |
-11,233
| Closed | -$44K | – | 1407 |
|
|
2018
Q1 | $44K | Buy |
+11,233
| New | +$44K | ﹤0.01% | 1032 |
|
|
2015
Q3 | – | Sell |
-2,061
| Closed | -$40K | – | 862 |
|
|
2015
Q2 | $40K | Buy |
+2,061
| New | +$40K | 0.01% | 570 |
|
|
2014
Q3 | – | Sell |
-2,583
| Closed | -$73K | – | 966 |
|
|
2014
Q2 | $73K | Buy |
+2,583
| New | +$73K | 0.01% | 577 |
|